eScholarship
metadata only
CC BY
Routine Screening for Neuroblastoma in Harlequin Syndrome Without Otherwise Known Etiology
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Response-based Treatment of High-risk Neuroblastoma#424172
- Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)#353290
- Tumoren und paraneoplastische Syndrome / by: Steinbach, Joachim#1353747
- Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.#1087207
- The history of the harlequinade, volume 2 (of 2)#65802
Record · ID 1424939
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive